European Archives - Page 68 of 1629 - European Medical Journal

immune reconstitution

Immune Reconstitution and Viral Reactivation After HSCT

Immune reconstitution after allogeneic HSCT showed distinct associations with CMV and EBV reactivation, while viral reactivation was not linked to survival.

Nasal Fluid Proteins Linked to Respiratory Symptom Burden

An exploratory study found that nasal fluid proteins TRAIL and CXCL10 were associated with respiratory symptom burden, supporting further investigation of nasal biomarkers.

Older Adults Show Rising Arrhythmia Mortality Risk – EMJ

Rising Arrhythmia Mortality Seen in Older Adults

A nationwide analysis of older adults found a recent rise in mortality linked to arrhythmia and cerebrovascular disease, with important differences by sex, ethnicity, geography, and place of death.

Person in white gloves drawing from a vaccine vial

Lyme disease vaccine candidate moves towards EU review

Pfizer and Valneva’s candidate is closer to a potential European approval after the EMA validated the marketing authorisation application.

Biomarkers Predict SSc-ILD Progression - EMJ

SENSCIS Trial Reveals Key Biomarkers in SSc-ILD

A blood biomarker was linked to faster lung decline in systemic sclerosis-associated interstitial lung disease, a SENSCIS analysis found.

Tofacitinib for Dermal Hyperpigmentation - EMJ

Oral Tofacitinib Showed Modest Improvement in Dermal Hyperpigmentation

A 24 week pilot study found that oral tofacitinib produced modest but significant improvements in acquired dermal macular hyperpigmentation, with early response predicting longer term benefit.

Amyloid Levels Linked to Postoperative Delirium - EMJ

Amyloid-β Levels Linked to Delirium After Cardiac Surgery

Elevated plasma amyloid-β 1-40 was linked to higher delirium risk after cardiac surgery in older patients, a new study found.

Lung Cancer Treatment Duration And Specialists - EMJ

Lung Cancer Treatment Duration Examined Across Japan

A national study found longer recorded lung cancer treatment duration at facilities with more specialists, but adjusted analyses showed no significant association.

Adjuvant Capecitabine: Real-World Data in BTC - EMJ

Adjuvant Capecitabine Shows No Significant Benefit in Biliary Cancer

Adjuvant capecitabine showed no significant survival benefit in a French real-world study of patients with resected biliary tract cancer, despite a trend towards longer RFS.

Gut Microbiome Signatures Linked to Obesity

Multi-omics research identifies gut bacteria and serum metabolites associated with obesity, revealing potential microbiome–metabolome interactions.